150 related articles for article (PubMed ID: 29312569)
41. Water Extract of Dolichos lablab Attenuates Hepatic Lipid Accumulation in a Cellular Nonalcoholic Fatty Liver Disease Model.
Im AR; Kim YH; Lee HW; Song KH
J Med Food; 2016 May; 19(5):495-503. PubMed ID: 27152979
[TBL] [Abstract][Full Text] [Related]
42. The Dipeptidyl Peptidase-4 Inhibitor Teneligliptin Attenuates Hepatic Lipogenesis via AMPK Activation in Non-Alcoholic Fatty Liver Disease Model Mice.
Ideta T; Shirakami Y; Miyazaki T; Kochi T; Sakai H; Moriwaki H; Shimizu M
Int J Mol Sci; 2015 Dec; 16(12):29207-18. PubMed ID: 26670228
[TBL] [Abstract][Full Text] [Related]
43. GLP-1 analogue improves hepatic lipid accumulation by inducing autophagy via AMPK/mTOR pathway.
He Q; Sha S; Sun L; Zhang J; Dong M
Biochem Biophys Res Commun; 2016 Aug; 476(4):196-203. PubMed ID: 27208776
[TBL] [Abstract][Full Text] [Related]
44. Exercise Alleviates the Apolipoprotein A5-Toll-Like Receptor 4 Axis Impairment in Mice With High-Fat Diet-Induced Non-alcoholic Steatohepatitis.
Yu Y; Yu L; Cheng N; Liu X; Fang C; Liu S; Zhu L
Front Physiol; 2021; 12():783341. PubMed ID: 35035359
[No Abstract] [Full Text] [Related]
45. Liver X receptor (LXR)-beta regulation in LXRalpha-deficient mice: implications for therapeutic targeting.
Quinet EM; Savio DA; Halpern AR; Chen L; Schuster GU; Gustafsson JA; Basso MD; Nambi P
Mol Pharmacol; 2006 Oct; 70(4):1340-9. PubMed ID: 16825483
[TBL] [Abstract][Full Text] [Related]
46. Betaine prevented fructose-induced NAFLD by regulating LXRα/PPARα pathway and alleviating ER stress in rats.
Ge CX; Yu R; Xu MX; Li PQ; Fan CY; Li JM; Kong LD
Eur J Pharmacol; 2016 Jan; 770():154-64. PubMed ID: 26593707
[TBL] [Abstract][Full Text] [Related]
47. Viscothionin isolated from Korean mistletoe improves nonalcoholic fatty liver disease via the activation of adenosine monophosphate-activated protein kinase.
Kim S; Lee D; Kim JK; Kim JH; Park JH; Lee JW; Kwon J
J Agric Food Chem; 2014 Dec; 62(49):11876-83. PubMed ID: 25383453
[TBL] [Abstract][Full Text] [Related]
48. Metformin and salicylate synergistically activate liver AMPK, inhibit lipogenesis and improve insulin sensitivity.
Ford RJ; Fullerton MD; Pinkosky SL; Day EA; Scott JW; Oakhill JS; Bujak AL; Smith BK; Crane JD; Blümer RM; Marcinko K; Kemp BE; Gerstein HC; Steinberg GR
Biochem J; 2015 May; 468(1):125-32. PubMed ID: 25742316
[TBL] [Abstract][Full Text] [Related]
49. Magnolia officinalis attenuates free fatty acid-induced lipogenesis via AMPK phosphorylation in hepatocytes.
Seo MS; Hong SW; Yeon SH; Kim YM; Um KA; Kim JH; Kim HJ; Chang KC; Park SW
J Ethnopharmacol; 2014 Nov; 157():140-8. PubMed ID: 25261688
[TBL] [Abstract][Full Text] [Related]
50. Mechanism of Altered Metformin Distribution in Nonalcoholic Steatohepatitis.
Clarke JD; Dzierlenga AL; Nelson NR; Li H; Werts S; Goedken MJ; Cherrington NJ
Diabetes; 2015 Sep; 64(9):3305-13. PubMed ID: 26016715
[TBL] [Abstract][Full Text] [Related]
51. Hydrogen sulfide reduces serum triglyceride by activating liver autophagy via the AMPK-mTOR pathway.
Sun L; Zhang S; Yu C; Pan Z; Liu Y; Zhao J; Wang X; Yun F; Zhao H; Yan S; Yuan Y; Wang D; Ding X; Liu G; Li W; Zhao X; Liu Z; Li Y
Am J Physiol Endocrinol Metab; 2015 Dec; 309(11):E925-35. PubMed ID: 26442880
[TBL] [Abstract][Full Text] [Related]
52. Acanthoic acid protectsagainst ethanol-induced liver injury: Possible role of AMPK activation and IRAK4 inhibition.
Yao YL; Han X; Song J; Zhang J; Li YM; Lian LH; Wu YL; Nan JX
Toxicol Lett; 2017 Nov; 281():127-138. PubMed ID: 28964808
[TBL] [Abstract][Full Text] [Related]
53. Schisandra polysaccharide inhibits hepatic lipid accumulation by downregulating expression of SREBPs in NAFLD mice.
Wang CM; Yuan RS; Zhuang WY; Sun JH; Wu JY; Li H; Chen JG
Lipids Health Dis; 2016 Nov; 15(1):195. PubMed ID: 27852305
[TBL] [Abstract][Full Text] [Related]
54. S-allyl cysteine attenuates free fatty acid-induced lipogenesis in human HepG2 cells through activation of the AMP-activated protein kinase-dependent pathway.
Hwang YP; Kim HG; Choi JH; Do MT; Chung YC; Jeong TC; Jeong HG
J Nutr Biochem; 2013 Aug; 24(8):1469-78. PubMed ID: 23465592
[TBL] [Abstract][Full Text] [Related]
55. [Statin reduced triglyceride level via activating peroxisome proliferator activated receptor α and upregulating apolipoprotein A5 in hypertriglyceridemic rats].
HUANG XS; ZHAO SP; BAI L; ZHANG Q; HU M; ZHAO W
Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Sep; 38(9):809-13. PubMed ID: 21092650
[TBL] [Abstract][Full Text] [Related]
56. Leptinomimetic effects of the AMP kinase activator AICAR in leptin-resistant rats: prevention of diabetes and ectopic lipid deposition.
Yu X; McCorkle S; Wang M; Lee Y; Li J; Saha AK; Unger RH; Ruderman NB
Diabetologia; 2004 Nov; 47(11):2012-21. PubMed ID: 15578153
[TBL] [Abstract][Full Text] [Related]
57. Effects of the new thiazolidine derivative LPSF/GQ-02 on hepatic lipid metabolism pathways in non-alcoholic fatty liver disease (NAFLD).
Araújo S; Soares E Silva A; Gomes F; Ribeiro E; Oliveira W; Oliveira A; Lima I; Lima MDC; Pitta I; Peixoto C
Eur J Pharmacol; 2016 Oct; 788():306-314. PubMed ID: 27349145
[TBL] [Abstract][Full Text] [Related]
58. Pyruvate dehydrogenase kinase 4 mediates lipogenesis and contributes to the pathogenesis of nonalcoholic steatohepatitis.
Zhang M; Zhao Y; Li Z; Wang C
Biochem Biophys Res Commun; 2018 Jan; 495(1):582-586. PubMed ID: 29128353
[TBL] [Abstract][Full Text] [Related]
59. iPLA2β deficiency attenuates obesity and hepatic steatosis in ob/ob mice through hepatic fatty-acyl phospholipid remodeling.
Deng X; Wang J; Jiao L; Utaipan T; Tuma-Kellner S; Schmitz G; Liebisch G; Stremmel W; Chamulitrat W
Biochim Biophys Acta; 2016 May; 1861(5):449-61. PubMed ID: 26873633
[TBL] [Abstract][Full Text] [Related]
60. Hepatic Steatosis Alleviated by a Novel Metformin and Quercetin Combination Activating Autophagy Through the cAMP/AMPK/SIRT1 Pathway.
Afshari H; Noori S; Zarghi A
Iran J Pharm Res; 2023; 22(1):e136952. PubMed ID: 38116565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
